Tildrakizumab-asmn generic Tildrakizumab-asmn is an interleukin-23 antagonist which is prescribed for treating adults suffering from moderate to severe plaque psoriasis who may benefit with systemic therapy or phototherapy. Tildrakizumab-asmn is a monoclonal antibody which works by binding to interleukin-23 and blocking it from attaching to its receptor; it thus reduces the release of cytokines and chemokines which are responsible for causing inflammation.
More Info about Tildrakizumab-asmn